Naba Al Saha Medical Services Company (TADAWUL: 9546)

Naba Al Saha Medical Services Company Statistics

Total Valuation

Naba Al Saha Medical Services Company has a market cap or net worth of SAR 864.15 million. The enterprise value is 908.76 million.

Market Cap	864.15M
Enterprise Value	908.76M

Important Dates

The next estimated earnings date is Thursday, November 28, 2024.

Earnings Date	Nov 28, 2024
Ex-Dividend Date	n/a

Share Statistics

Naba Al Saha Medical Services Company has 10.50 million shares outstanding.

Shares Outstanding	10.50M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	69.50%
Owned by Institutions (%)	0.00%
Float	1.94M

Valuation Ratios

The trailing PE ratio is 22.95.

PE Ratio	22.95
Forward PE	n/a
PS Ratio	4.39
PB Ratio	4.47
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.56, with an EV/FCF ratio of -49.13.

EV / Earnings	24.13
EV / Sales	4.62
EV / EBITDA	18.56
EV / EBIT	23.39
EV / FCF	-49.13

Financial Position

The company has a current ratio of 3.49, with a Debt / Equity ratio of 0.28.

Current Ratio	3.49
Quick Ratio	3.08
Debt / Equity	0.28
Debt / EBITDA	1.07
Debt / FCF	-2.90
Interest Coverage	184.82

Financial Efficiency

Return on equity (ROE) is 21.59% and return on invested capital (ROIC) is 11.55%.

Return on Equity (ROE)	21.59%
Return on Assets (ROA)	9.72%
Return on Capital (ROIC)	11.55%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.77
Inventory Turnover	10.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.33% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+38.33%
50-Day Moving Average	92.77
200-Day Moving Average	84.33
Relative Strength Index (RSI)	38.80
Average Volume (20 Days)	1,653

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Naba Al Saha Medical Services Company had revenue of SAR 196.78 million and earned 37.66 million in profits. Earnings per share was 3.59.

Revenue	196.78M
Gross Profit	69.67M
Operating Income	39.87M
Pretax Income	40.45M
Net Income	37.66M
EBITDA	48.39M
EBIT	39.87M
Earnings Per Share (EPS)	3.59

Balance Sheet

The company has 9.00 million in cash and 53.61 million in debt, giving a net cash position of -44.61 million or -4.25 per share.

Cash & Cash Equivalents	9.00M
Total Debt	53.61M
Net Cash	-44.61M
Net Cash Per Share	-4.25
Equity (Book Value)	193.14M
Book Value Per Share	18.39
Working Capital	86.14M

Cash Flow

In the last 12 months, operating cash flow was 35.84 million and capital expenditures -54.34 million, giving a free cash flow of -18.50 million.

Operating Cash Flow	35.84M
Capital Expenditures	-54.34M
Free Cash Flow	-18.50M
FCF Per Share	-1.76

Margins

Gross margin is 35.41%, with operating and profit margins of 20.26% and 19.14%.

Gross Margin	35.41%
Operating Margin	20.26%
Pretax Margin	20.56%
Profit Margin	19.14%
EBITDA Margin	24.59%
EBIT Margin	20.26%
FCF Margin	-9.40%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.24%.

Dividend Per Share	0.20
Dividend Yield	0.24%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	5.58%
Buyback Yield	n/a
Shareholder Yield	0.24%
Earnings Yield	4.36%
FCF Yield	-2.14%

Stock Splits

The last stock split was on November 20, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	Nov 20, 2023
Split Type	Forward
Split Ratio	1.5

Scores

Naba Al Saha Medical Services Company has an Altman Z-Score of 6.37.

Altman Z-Score	6.37
Piotroski F-Score	n/a